|Bid||73.57 x 1000|
|Ask||73.75 x 800|
|Day's Range||70.90 - 77.28|
|52 Week Range||12.52 - 105.00|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 11, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||75.57|
What happened Shares of German clinical-stage biotech BioNTech (NASDAQ: BNTX) jumped 23% July, according to data from S&P Global Market Intelligence. For context, the S&P 500 index returned 5.6% last month.
In the latest trading session, BioNTech SE Sponsored ADR (BNTX) closed at $77, marking a -0.1% move from the previous day.
The conversation around pricing vaccinations and distribution is ramping up as more pharmaceuticals announce positive test results. Dr. Rob Davidson, a West Michigan ER doctor and the Executive Director of the Committee to Protect Medicare, joins The Final Round panel to discuss his views on the coronavirus vaccine front.